APPLICATION TEST RESULTS Immediately: Noticeable brightening of the eye area and reduction of fine lines After 4 weeks: Smoother skin, reduced dark circles, and even skin tone After 8 weeks: Visibly smoother lines, brighter under-eyes, and a more even, radiant tone
They are chemically compatible for short-term co-administration
Tirzepatide is a novel dual-acting peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a glucagon-like peptide-1 (GLP-1) receptor agonist
Exfoliating acids: Alpha-hydroxy acids and beta-hydroxy acids remove dead skin cells for a smoother, brighter complexion
See what patients with similar goals are running at Perfect B
Preclinical data suggest it stabilizes multiple neurotransmitter systemsacetylcholine, dopamine, serotonin, and GABApointing to potential effects on the gut-brain axis that extend beyond local tissue repair PMID: 40789979